Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Redemption of units for cash	Redemption of units for stock	Series B Units Redemption of units for cash	Series B Units Redemption of units for stock	Series D Units	Series D Units Redemption of units for stock	Preferred Operating Partnership	Preferred Operating Partnership Series B Units Redemption of units for cash	Preferred Operating Partnership Series B Units Redemption of units for stock	Preferred Operating Partnership Series D Units	Preferred Operating Partnership Series D Units Redemption of units for stock	Operating Partnership	Operating Partnership Redemption of units for cash	Operating Partnership Redemption of units for stock	Other	Common Stock	Common Stock Redemption of units for stock	Common Stock Series B Units Redemption of units for stock	Common Stock Series D Units Redemption of units for stock	Additional Paid-in Capital	Additional Paid-in Capital Redemption of units for cash	Additional Paid-in Capital Redemption of units for stock	Additional Paid-in Capital Series B Units Redemption of units for stock	Additional Paid-in Capital Series D Units Redemption of units for stock	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance at Dec. 31, 2019	$ 2,921,694							$ 175,948					$ 205,419			$ 366	$ 1,295				$ 2,868,681					$ (28,966)	$ (301,049)
Beginning balance (in shares) at Dec. 31, 2019																	129,534,407
Increase (Decrease) in Stockholders' Equity
Issuance of common stock upon the exercise of options	$ 4,759																$ 1				4,758
Issuance of common stock upon the exercise of options (in shares)	134,930																134,930
Issuance of common stock in connection with share based compensation	$ 16,281																$ 1				16,280
Issuance of common stock in connection with share based compensation (in shares)																	143,187
Restricted stock grants cancelled (in shares)																	(5,083)
Issuance of common stock, net of offering costs	103,468																$ 9				103,459
Issuance of common stock, net of offering costs (in shares)																	899,048
Redemption of noncontrolling interests	0			$ (1,000)			$ 0		$ (1,000)			$ (2,724)			$ (4,572)			$ 1		$ 1			$ 4,571		$ 2,723
Redemption of noncontrolling interests (in shares)																		123,993		30,495
Buyback of common stock, net of offering costs	(67,873)																$ (8)										(67,865)
Buyback of common stock, net of offering costs (in shares)																	(826,797)
Repayment of receivable with Preferred operating units pledged as collateral on loan	16,213												16,213
Repurchase of equity portion of 2015 exchangeable senior notes	0																	$ 14					(14)
Repurchase of equity portion of 2015 exchangeable senior notes (in shares)																		1,323,781
Noncontrolling interest in consolidated joint venture	66															66
Net income	517,582							12,882					22,952			(31)											481,779
Other comprehensive income (loss)	(73,686)							(456)					(3,103)													(70,127)
Distributions to Operating Partnership units held by noncontrolling interests	(33,615)							(12,598)					(21,017)
Dividends paid on common stock	(467,765)																										(467,765)
Ending balance at Dec. 31, 2020	2,936,124							172,052					215,892			401	$ 1,314				3,000,458					(99,093)	(354,900)
Ending balance (in shares) at Dec. 31, 2020																	131,357,961
Increase (Decrease) in Stockholders' Equity
Issuance of common stock upon the exercise of options	$ 4,572																				4,572
Issuance of common stock upon the exercise of options (in shares)	62,322																62,322
Issuance of common stock in connection with share based compensation	$ 17,303																				17,303
Issuance of common stock in connection with share based compensation (in shares)																	148,228
Restricted stock grants cancelled (in shares)																	(12,808)
Issuance of common stock, net of offering costs	273,189																$ 22				273,167
Issuance of common stock, net of offering costs (in shares)																	2,185,685
Redemption of noncontrolling interests		$ (788)	$ 0		$ 0					$ (2,834)				$ (173)	$ (6,373)			$ 2	$ 1			$ (615)	$ 6,371	$ 2,833
Redemption of noncontrolling interests (in shares)																		165,652	15,265
Repayment of receivable with Operating Partnership units pledged as collateral	411												411
Issuance of Operating Partnership units in conjunction with acquisitions	188,319					$ 88,074					$ 88,074		188,319
Purchase of remaining equity interest in existing consolidated joint venture	(18,141)																				(18,141)
Noncontrolling interest in consolidated joint venture	(82)															(82)
Net income	877,758							14,697					35,414			(2)											827,649
Other comprehensive income (loss)	59,325							366					2,412													56,547
Distributions to Operating Partnership units held by noncontrolling interests	(39,094)							(13,245)					(25,849)
Dividends paid on common stock	(600,994)																										(600,994)
Ending balance at Dec. 31, 2021	$ 3,785,976							259,110					410,053			317	$ 1,339				3,285,948					(42,546)	(128,245)
Ending balance (in shares) at Dec. 31, 2021	133,922,305																133,922,305
Increase (Decrease) in Stockholders' Equity
Issuance of common stock upon the exercise of options (in shares)	0
Issuance of common stock in connection with share based compensation	$ 21,388																$ 2				21,386
Issuance of common stock in connection with share based compensation (in shares)																	204,349
Restricted stock grants cancelled (in shares)																	(10,614)
Redemption of noncontrolling interests		$ (4,617)		$ (4,500)					$ (4,500)					$ (1,654)								$ (2,963)
Buyback of common stock, net of offering costs	$ (63,008)																$ (4)										(63,004)
Buyback of common stock, net of offering costs (in shares)	(381,786)																(381,786)
Issuance of Operating Partnership units in conjunction with business combination	$ 16,000												16,000
Issuance of Operating Partnership units in conjunction with acquisitions	125,000												125,000
Issuance of Preferred D units in the Operating Partnership in conjunction with business combination						$ 6,000					$ 6,000
Issuance of common stock in conjunction with acquisition (in shares)																	186,766
Issuance of common stock in conjunction with acquisitions	40,963																$ 2				40,961
Noncontrolling interest in consolidated joint venture	771															771
Net income	921,156							17,623					42,853			(8)											860,688
Other comprehensive income (loss)	96,249							577					4,328													91,344
Distributions to Operating Partnership units held by noncontrolling interests	(57,793)							(17,308)					(40,485)
Dividends paid on common stock	(805,311)																										(805,311)
Ending balance at Dec. 31, 2022	$ 4,078,274							$ 261,502					$ 556,095			$ 1,080	$ 1,339				$ 3,345,332					$ 48,798	$ (135,872)
Ending balance (in shares) at Dec. 31, 2022	133,921,020																133,921,020